Karen Y Kuo, MD

Article

Enhanced Radiation Dermatitis Associated With Concurrent Palliative Radiation and Vemurafenib Therapy

Author:: Karen Y Kuo, MD

Publish date: August 8, 2016

Vemurafenib is a selective BRAF inhibitor that was approved by the US Food and Drug Administration (FDA) in August 2011 for the treatment of patien...